Magdalena Teague-Sobieraj is a hematologist-oncologist based in Bedford Park, SA, Australia.
She works with people who have blood cancers and other serious blood conditions. That can include lymphomas, especially Marginal Zone Lymphoma (MZL) and other B-Cell lymphomas. At times, these illnesses can be slow to change, and at other times they can move faster. Either way, she focuses on clear, practical care and helps patients understand what’s happening and what the next steps might be.
Magdalena also looks after patients with clotting and bleeding issues. Deep Vein Thrombosis (DVT) and Venous Thromboembolism (VTE) are common examples. She also deals with specific clotting problems like Mesenteric Venous Thrombosis and Protein C Deficiency. These conditions can be confusing and scary, especially when symptoms come on suddenly. In many cases, getting the right tests and treatment early makes a real difference.
There are other tricky situations she manages too. She has experience with Hemolytic Transfusion Reaction, which is a reaction that can happen after a blood transfusion. She also works with cases where hypothermia is part of the picture, since temperature and body balance matter for how well people recover.
In day-to-day practice, she aims for calm, careful decision-making. She knows that blood conditions often affect more than one part of health. For example, treatment plans may need to take clot risk, recovery time, and overall wellbeing into account. Over time, she helps patients and families sort through options and stay on track with follow-ups.
Her role sits in between oncology and haematology, which means she understands both the cancer side and the blood side. That can be helpful when a patient’s situation is not simple, or when there are several issues happening at once. She tends to keep things grounded—explaining what’s most important right now and what can wait.
If you’re looking for a doctor in Bedford Park who works with blood cancers and clotting problems, Magdalena Teague-Sobieraj is there to help with a wide range of hematology-oncology concerns.
